HYDROXYLAMINE DERIVATIVES USEFUL FOR ENHANCING THE MOLECULARCHAPERON PRODUCTION AND THE PREPARATION THEREOF

• Main Authors: KOVACS, ESZTER, UDVARDY, EVA, JASZLITS, LASZLO, JEDNAKOVITS, ANDREA, MARVANYOS, EDE, UROGDI, LASZLO, KURTHY, MARIA, DUDA, ERNO, HORVATH, IBOLYA, FARKAS, BEATRIX, SZILBEREKY, JENO, TOROK, ZSOLT, VIGH, LASZLO, MEZES, BEA, GLATZ, ATTILA, HEGEDUS, ERZSEBET, BALOGH, GABOR, MEDZIHRADSZKY, DENES, BIRO, KATALIN, LITERATI NAGY, PETER, KORANYI, LASZLO, DORMAN, GYORGY, BARABAS, MIHALY
• Format: Patent
• Language: English; French
• Published: 19.05.2009
• Subjects: ACYCLIC OR CARBOCYCLIC COMPOUNDS; BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS THEREOF; CULTURE MEDIA; ENZYMOLOGY; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE; HETEROCYCLIC COMPOUNDS; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MICROORGANISMS OR ENZYMES; MUTATION OR GENETIC ENGINEERING; ORGANIC CHEMISTRY; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PROCESSES USING MICROORGANISMS; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; SPIRITS; VINEGAR; WINE

A method of increasing expression of a molecular chaperon by a cell and/or enhancing the activity of a molecular chaperon in cells is provided. The method comprises treating a cell that is exposed to a physiological stress which induces expression of a molecular chaperon by the cell with an effective amount of a certain hydroxylamine derivative t o increase the stress. Alternatively, a hydroxylamine derivative can be administrated to a cell before it is exposed to a physiological stres s which induces expression of a molecular chaperon by the cell. Preferably, the cell to which a hydroxylamine derivative is administered is a eukaryotic cell. The hydroxylamine derivative corresponds to the formulae (I) or (II). The invention also provides novel hydroxylamine derivatives falling within the scope of the formulae (I) and (II) as well as pharmaceutical and/or cosmetical compositions comprising the said compounds.